MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. [PDF]
Clin Exp Immunol, 2021 Elhadad S +5 more
europepmc +1 more source
The Interaction Between Coagulation and Complement Cascades in the Management of Thrombotic Microangiopathies Related to Postpartum Hemorrhage. [PDF]
Kidney Int RepOrsi M, Ossola MW, Cetin I, Ardissino G.
europepmc +1 more source
Pathogenesis of thrombotic microangiopathy: insights from animal models
Animal models are important experimental tools for investigating the molecular mechanisms, environmental and genetic susceptibilities underlying the development of thrombotic microangiopathies.
Richards A, Kavanagh D
core
Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies. [PDF]
Clin J Am Soc Nephrol, 2019 Fakhouri F, Frémeaux-Bacchi V.
europepmc +1 more source
HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies. [PDF]
Hematol Transfus Cell TherPandey S +4 more
europepmc +1 more source
When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy. [PDF]
J Thromb Thrombolysis, 2020 Murphree CR +3 more
europepmc +1 more source
Understanding thrombotic microangiopathies in children. [PDF]
Intensive Care Med, 2018 Joly BS, Zheng XL, Veyradier A.
europepmc +1 more source